SEC Form 4 · accession 0001102624-15-000406
Boston Therapeutics, Inc. · BTHE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Alan M Hoberman
Director
Period of report
Mar 10, 2015
Accepted (ET)
Mar 16, 2015 · 2:52 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001473579
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 10, 2015 | P | 5,000 | $0.22 | A | 5,000 | D |
Table II — derivative securities
No Table II lines on this filing.